Monika Berger

Title: Monika Berger: Innovator in Polysaccharide Production

Introduction

Monika Berger is a notable inventor based in Sehnde, Germany. She has made significant contributions to the field of biotechnology, particularly in the production of polysaccharides for vaccine development. With a total of two patents to her name, her work has the potential to impact the medical and pharmaceutical industries.

Latest Patents

Monika Berger's latest patents include innovative methods for producing phosphate-containing capsular polysaccharides. The first patent describes a host cell that contains a polynucleotide encoding a polypeptide capable of synthesizing a polysaccharide with a dimeric repeating unit. This invention also encompasses a vaccine composition that utilizes such host cells or the polypeptides they express for the production of glycoconjugate vaccines. The second patent focuses on in vitro methods for producing capsular polysaccharides of defined length. This invention includes compositions with capsule polymerases and specific ratios of donor to acceptor carbohydrates, as well as pharmaceuticals, particularly vaccines, that incorporate these synthetic polysaccharides.

Career Highlights

Throughout her career, Monika Berger has worked at the Medizinische Hochschule Hannover, where she has contributed to various research projects. Her expertise in polysaccharide production has positioned her as a key figure in her field.

Collaborations

Monika has collaborated with notable colleagues such as Timm Fiebig and Rita Gerardy-Schahn, enhancing her research through teamwork and shared expertise.

Conclusion

Monika Berger's innovative work in polysaccharide production showcases her dedication to advancing vaccine technology. Her patents reflect her commitment to improving healthcare solutions through scientific research and innovation.